期刊文献+

某社区2009年老年人高血压患病及相关因素分析 被引量:14

Analysis on Prevalence of Hypertension and Their Influencing Factors in a Community Crowd In 2009
原文传递
导出
摘要 目的分析某社区60周岁以上老年人高血压的患病、控制现状以及相关影响因素,为社区人群高血压的防治管理工作提供依据。方法 2009年对某社区60周岁以上常住居民1504人进行健康体检和问卷调查,应用Logistic回归分析的方法进行高血压的危险因素分析。结果高血压总患病率为60.4%,其中,女性既往患者患病率(39.3%)高于男性(32.7%),文盲组总患病率最高(70.2%)。既往患者规律服药率为92.3%,其中60~69岁组最高(95.1%)。既往患者高血压控制率为30.8%,其中女性(48.7%)高于男性(12.8%)。多因素Logistic回归分析表明,男性、超重、肥胖、吸烟、饮酒、文化程度、定期运动、规律服药是高血压患病率与控制率的重要影响因素。结论高血压是目前影响该社区60周岁及以上老年人健康的主要慢性病之一。本地区高血压患病率较高,控制率较低。女性规律服药率高于男性,规律服药率随着年龄的增大而降低,随着文化程度的提高而升高,80岁以上组规律服药率最低。 OBJECTIVE To discover the distributed features and controlling situation and influencing factors of the old patients with hypertension in a community, and provide suggestion for the community supervisory work of chronic illness. METHODS In 2009, we carried on the physical exam and the questionnaire survey in 1504 old residents (above 60 year) in a community crowd, and we carried out the relevant risk factors by Logistic regression analysis. RESULTS The total prevalence rate of hy pertension was 60.4%, which meaned that the prevalence rate for masculine used hypertension (32.7%) was smaller than the feminine's (39.3%), and the over prevalence rate of hypertension among illiterates was still high (70.2%) . Among the used patients, the rate of the hypertension's patients with regularly taking medicine respectively was 92.3%, where 60-group had the highest ratio (95.1%). The used hypertension's controlling rate was 30.8%, where the feminine hypertension's controlling rate (48.7%) was higher than the male's (12.8%). The multivariate Logistic regression analyses suggested that male, over weight and obsity, smoking and drinking, education, regular movement, regular-taking-medicine were the significant influ encing factors of hypertension. CONCLUSION The hypertension is one of the most important chronic illnesses among the above 60 years old in this community crowd.
出处 《现代预防医学》 CAS 北大核心 2012年第20期5288-5290,共3页 Modern Preventive Medicine
关键词 老年人高血压 患病率 控制率 LOGISTIC回归分析 Old people with hypertension Prevalence Controlling rate Logistic regression analysis
作者简介 雷红梅(1976-)女,硕士,主治医师,研究方向:内科
  • 相关文献

参考文献12

  • 1中国高血压防治指南修订委员会.中国高血压防治指南(2005年修仃版)[M].2005.24.
  • 2SWHO. 2003b. Diet, nutrition and the prevention of chronic disease titl. Geneva: World Health Organiztion, Technical Report Series No. 916.
  • 3Qureshi AL, Suri MF, Kirmanl JF, et al. Is prehypertension a risk factor for eavdiovaseular diseases [J]. Stroke, 2005, 36 (9) : 859-1863.
  • 4吴涛,詹思延,李立明,胡永华,曹卫华,李晓晖,李俊,王涛.社区高血压患者多代谢异常的流行病学特征分析[J].中华流行病学杂志,2000,21(3):181-184. 被引量:26
  • 5Kannel WB, Brand N, Skinner JJ, et al. The rehtion of adiposity to blood pressure and development of hypertension.the framingham study[J]. Ann Iniem Med, 1967, 67 (1): 48-59.
  • 6Morris AD, Petrie JR, Coanell JM. Insulin and hypertenslon[J]. J HyPertens, 1994, 43 (12): 633--642.
  • 7Manson JE, Nathan DM, Krolewski AS, et al. A prospective study ofexereise and incidence of diabetes among US male physicians EJ ]. JAMA, 1992, 268 (1): 63-67.
  • 8Iwasakl N, Cox NJ, Wang YQ, et a]. Mapping genes irdlurencing type 2 diabetes risk and bmi in japanese subjects [J]. J.Diabetes, 2003, 52 (1): 209-213.
  • 9胡予,陈世耀,王吉耀.糖尿病预防治疗的费用效益分析[J].中华流行病学杂志,2004,25(5):431-434. 被引量:2
  • 10Burke V, Beilin LJ, Cutt HE, et al. Effect of a lifestyle pro- gramme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a ramdomized controlled trial [J ]. Journal of Hypertension, 2005, 23 (6): 1241-1249.

二级参考文献8

  • 1郭丹杰,徐成斌.胰岛素抵抗与心血管病危险因素聚集性关系研究[J].中华内科杂志,1997,36(4):250-252. 被引量:19
  • 2王淑娟,现代实验诊断学手册,1995年,563页
  • 3Wei Chen,Am J Epidemiol,1999年,150卷,667页
  • 4Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin-Diabetes Prevention Program Research Group. N Engl J Med,2002, 346∶393-403.
  • 5Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet,2002, 359∶2072-2077.
  • 6Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.DPP research group. Diabetes Care,2003,26∶2518-2523.
  • 7Hernan WH,Brabdle M, Zhang P, et al. Costs assicuated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care,2003,26∶36-47.
  • 8Slama G. The potential of metformin for diabetes prevention. Diabetes Metab,2003,29∶s104-s111.

共引文献26

同被引文献116

引证文献14

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部